Seffernick A, Cao X, Cheng C, Yang W, Autry R, Yang J
bioRxiv. 2024; .
PMID: 39131398
PMC: 11312528.
DOI: 10.1101/2024.07.31.605805.
Nguyen H, Pham V, Nguyen H, Tran B, Petereit J, Nguyen T
Brief Bioinform. 2024; 25(Supplement_1).
PMID: 39041916
PMC: 11264295.
DOI: 10.1093/bib/bbae222.
Deng X, Thompson J
Res Sq. 2023; .
PMID: 37841872
PMC: 10571627.
DOI: 10.21203/rs.3.rs-3367968/v1.
Fuh-Ngwa V, Charlesworth J, Zhou Y, van der Mei I, Melton P, Broadley S
Sci Rep. 2023; 13(1):11584.
PMID: 37463930
PMC: 10354053.
DOI: 10.1038/s41598-023-38415-z.
Fuh-Ngwa V, Zhou Y, Melton P, van der Mei I, Charlesworth J, Lin X
Sci Rep. 2022; 12(1):19291.
PMID: 36369345
PMC: 9652373.
DOI: 10.1038/s41598-022-23685-w.
Navigating Transcriptomic Connectivity Mapping Workflows to Link Chemicals with Bioactivities.
Shah I, Bundy J, Chambers B, Everett L, Haggard D, Harrill J
Chem Res Toxicol. 2022; 35(11):1929-1949.
PMID: 36301716
PMC: 10483698.
DOI: 10.1021/acs.chemrestox.2c00245.
cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines.
Cheng X, Liu Y, Wang J, Chen Y, Robertson A, Zhang X
Brief Bioinform. 2022; 23(3).
PMID: 35368077
PMC: 9116376.
DOI: 10.1093/bib/bbac090.
Developing a clinical-environmental-genotypic prognostic index for relapsing-onset multiple sclerosis and clinically isolated syndrome.
Fuh-Ngwa V, Zhou Y, Charlesworth J, Ponsonby A, Simpson-Yap S, Lechner-Scott J
Brain Commun. 2021; 3(4):fcab288.
PMID: 34950873
PMC: 8691056.
DOI: 10.1093/braincomms/fcab288.
Multi-marker genetic association and interaction tests with interval-censored survival outcomes.
Wu D, Li C, Lu Q
Genet Epidemiol. 2021; 45(8):860-873.
PMID: 34472134
PMC: 8604754.
DOI: 10.1002/gepi.22429.
Globaltest confidence regions and their application to ridge regression.
Xu N, Solari A, Goeman J
Biom J. 2021; 63(7):1351-1365.
PMID: 34046931
PMC: 8519024.
DOI: 10.1002/bimj.202000063.
Association between patterns of alcohol consumption (beverage type, frequency and consumption with food) and risk of adverse health outcomes: a prospective cohort study.
Jani B, McQueenie R, Nicholl B, Field R, Hanlon P, Gallacher K
BMC Med. 2021; 19(1):8.
PMID: 33430840
PMC: 7802201.
DOI: 10.1186/s12916-020-01878-2.
Set-based genetic association and interaction tests for survival outcomes based on weighted V statistics.
Li C, Wu D, Lu Q
Genet Epidemiol. 2020; 45(1):46-63.
PMID: 32896012
PMC: 8074363.
DOI: 10.1002/gepi.22353.
Marginal screening for high-dimensional predictors of survival outcomes.
Huang T, McKeague I, Qian M
Stat Sin. 2020; 29(4):2105-2139.
PMID: 31938013
PMC: 6959482.
DOI: 10.5705/ss.202017.0298.
HisCoM-PAGE: Hierarchical Structural Component Models for Pathway Analysis of Gene Expression Data.
Mok L, Kim Y, Lee S, Choi S, Lee S, Jang J
Genes (Basel). 2019; 10(11).
PMID: 31739607
PMC: 6896173.
DOI: 10.3390/genes10110931.
Weighted gene co‑expression network analysis for identifying hub genes in association with prognosis in Wilms tumor.
Wang X, Song P, Huang C, Yuan N, Zhao X, Xu C
Mol Med Rep. 2019; 19(3):2041-2050.
PMID: 30664180
PMC: 6390024.
DOI: 10.3892/mmr.2019.9881.
Integrated analysis of a competing endogenous RNA network reveals key lncRNAs as potential prognostic biomarkers for human bladder cancer.
Zhu N, Hou J, Wu Y, Liu J, Li G, Zhao W
Medicine (Baltimore). 2018; 97(35):e11887.
PMID: 30170380
PMC: 6392549.
DOI: 10.1097/MD.0000000000011887.
Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content.
Sandberg T, Oosting J, van Pelt G, Mesker W, Tollenaar R, Morreau H
Oncotarget. 2018; 9(59):31502-31515.
PMID: 30140386
PMC: 6101138.
DOI: 10.18632/oncotarget.25845.
A highly adaptive microbiome-based association test for survival traits.
Koh H, Livanos A, Blaser M, Li H
BMC Genomics. 2018; 19(1):210.
PMID: 29558893
PMC: 5859547.
DOI: 10.1186/s12864-018-4599-8.
Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer.
Yuan N, Zhang G, Bie F, Ma M, Ma Y, Jiang X
Onco Targets Ther. 2017; 10:5883-5897.
PMID: 29276392
PMC: 5731337.
DOI: 10.2147/OTT.S149308.
Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables.
Mes S, Te Beest D, Poli T, Rossi S, Scheckenbach K, van Wieringen W
Oncotarget. 2017; 8(35):59312-59323.
PMID: 28938638
PMC: 5601734.
DOI: 10.18632/oncotarget.19576.